Science in Sport (SiS) has made three key senior management appointments.
Richard Wyborn has been appointed as group strategic projects director, and has worked for over a decade as a strategic consultant and project manager at global businesses.
His early focus will be on introducing the recently acquired PhD brand to the USA, and combining its operations with the existing SiS brand in that territory. He will also develop the group’s international strategy and structure to maximise opportunities in existing and new markets, with China a particular focus.
In addition, he will support existing teams on the launch of a new PhD e-commerce platform and support the integration of PhD protein manufacture into the SiS manufacturing facility in Nelson, Lancashire. Both of these projects are on track to launch in the coming months. He will join the business on 11th March.
James Morton has been appointed as group chief scientific officer, and is a professor of Exercise Metabolism and Nutrition at Liverpool John Moores University.
Since 2015 he has also been head of performance nutrition for Team Sky, and was head of nutrition at Liverpool FC from 2010 to 2015. He has consulted on a part-time basis for SiS as world class knowledge director in recent years. Going forwards, his focus will be to further develop new science claims and intellectual property across the group’s innovation pipeline. He will join the business on 1st April 2019.
Richard Whitty has been appointed as SiS marketing director, and was most recently global marketing manager for Carlsberg and led work across its recent rebrand and football activations. Prior to that he spent six years with Unilever in global marketing roles on a number of major portfolio brands.
He will be responsible for marketing strategy and activation across all key global markets for the SiS brand, with particular focus on commercialising the innovation pipeline. He will join the business on 26th February 2019.
Stephen Moon, CEO of SiS, said: “Science in Sport continues to attract leading talent and these three appointments typify our focus on growth and global ambitions. Our intent is to become the world’s leading premium performance nutrition business through investment in science, innovation and brand equity and this calibre of new talent is another step in realising that ambition.”